{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:45:40Z","timestamp":1791499540553,"version":"4.3.4"},"reference-count":82,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is typically associated with a dysregulated adipokine profile. C1q tumour necrosis factor-related protein 1 (CTRP1) is a relatively novel adipokine with protective metabolic effects, including improved insulin sensitivity. Clinical studies have increasingly highlighted a potential association between circulating CTRP1 and T2DM. Therefore, this systematic review and meta-analysis aimed to synthesise existing data on the association between circulating CTRP1 concentrations and T2DM in adults. MEDLINE, EMBASE, Cochrane Library, Web of Science, CINAHL and PsycInfo databases were searched for studies measuring circulating CTRP1 in adults with T2DM and controls. Eligible data were meta-analysed, reporting the mean difference (MD) and 95% confidence intervals (CIs) of circulating CTRP1 concentrations between T2DM cases and controls. The Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions (RoBANS 2) and the National Institutes of Health (NIH) quality assessment tool were utilised for study risk of bias and quality assessments, respectively. Eight studies (525 T2DM cases; 612 non-T2DM controls) were eligible for meta-analysis, showing significantly higher circulating CTRP1 concentrations in T2DM cases than controls (MD: 185.31 ng\/mL; 95% CI: 140.02 to 230.60; p &lt; 0.001). Most included studies were cross-sectional, and considerable heterogeneity was noted, with five studies having a high risk of bias in at least one RoBANS 2 domain. The MD remained relatively unchanged following a leave-one-out sensitivity analysis and exclusion of poor-quality studies. Meta-regression indicated that studies with a greater proportion of males (\u03b2 = \u2212188.68, p = 0.01) and higher mean body mass index (\u03b2 = \u221223.96, p = 0.02) were associated with a lower MD. These findings indicate that circulating CTRP1 concentrations are significantly higher in adults with T2DM compared to non-T2DM controls. Future prospective and large-scale studies are required to delineate the nature of this association and explore the potential of CTRP1 as a biomarker for T2DM. PROSPERO registration ID: CRD420251137104.<\/jats:p>","DOI":"10.3390\/ijms27156775","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:16:52Z","timestamp":1785313012000},"page":"6775","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating CTRP1 in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"27","author":[{"given":"Anirudh","family":"Suresh","sequence":"first","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2116-6654","authenticated-orcid":false,"given":"Alexander","family":"Dallaway","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Faculty of Education, Health, and Wellbeing, School of Health and Wellbeing, University of Wolverhampton, Wolverhampton WV1 1LY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attia","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK"},{"name":"Institute for Cardiometabolic Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV4 7AL, UK"},{"name":"Internal Medicine Department, Faculty of Medicine, Omar Al-Mukhtar University, Al-Bayda P.O. Box 919, Libya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-3672","authenticated-orcid":false,"given":"Lukasz","family":"Lagojda","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1342-274X","authenticated-orcid":false,"given":"Chris","family":"Kite","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Faculty of Education, Health, and Wellbeing, School of Health and Wellbeing, University of Wolverhampton, Wolverhampton WV1 1LY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-3439","authenticated-orcid":false,"given":"Ioannis","family":"Kyrou","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK"},{"name":"Institute for Cardiometabolic Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV4 7AL, UK"},{"name":"Discoveries in Life Sciences Research Centre, Coventry University, Coventry CV1 5FB, UK"},{"name":"Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK"},{"name":"College of Health, Psychology and Social Care, University of Derby, Derby DE22 1GB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal S.","family":"Randeva","sequence":"additional","affiliation":[{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK"},{"name":"Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK"},{"name":"Institute for Cardiometabolic Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV4 7AL, UK"},{"name":"Discoveries in Life Sciences Research Centre, Coventry University, Coventry CV1 5FB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","unstructured":"Feingold, K.R., Adler, R.A., Ahmed, S.F., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2026, March 13). Clinical Problems Caused by Obesity, Endotext, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278973\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: Clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Safiri, S., Karamzad, N., Kaufman, J.S., Bell, A.W., Nejadghaderi, S.A., Sullman, M.J.M., Moradi-Lakeh, M., Collins, G., and Kolahi, A. (2022). Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results from the Global Burden of Disease Study 2019. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.838027"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes\u2014Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Mart\u00edn, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: Principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41577-024-01103-8","article-title":"Adipokines: Masterminds of metabolic inflammation","volume":"25","author":"Tilg","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12020-017-1434-y","article-title":"Adiponectin circulating levels and 10-year (2002\u20132012) cardiovascular disease incidence: The ATTICA Study","volume":"58","author":"Kyrou","year":"2017","journal-title":"Endocrine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin Levels and Risk of Type 2 Diabetes","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41598-017-18709-9","article-title":"Plasma adiponectin levels and type 2 diabetes risk: A nested case-control study in a Chinese population and an updated meta-analysis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.56782\/pps.254","article-title":"Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: A case-control study","volume":"22","author":"Nayak","year":"2024","journal-title":"Prospect. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1186\/s40001-025-03188-w","article-title":"The mechanism of C1q\/TNF-related proteins (CTRPs) in atherosclerosis associated with type 2 diabetes mellitus","volume":"30","author":"Song","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.04.222","article-title":"The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events","volume":"286","author":"Muendlein","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"117913","DOI":"10.1016\/j.lfs.2020.117913","article-title":"The C1q\/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases","volume":"256","author":"Shanaki","year":"2020","journal-title":"Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20081240","article-title":"Molecular, biochemical and functional characterizations of C1q\/TNF family members: Adipose-tissue-selective expression patterns, regulation by PPAR-\u03b3 agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions","volume":"416","author":"Wong","year":"2008","journal-title":"Biochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"156162","DOI":"10.1016\/j.cyto.2023.156162","article-title":"CTRP1: A novel player in cardiovascular and metabolic diseases","volume":"164","author":"Wang","year":"2023","journal-title":"Cytokine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Schanbacher, C., Hermanns, H.M., Lorenz, K., Wajant, H., and Lang, I. (2023). Complement 1q\/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020559"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-022-03672-5","article-title":"CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice","volume":"20","author":"Ren","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1507\/endocrj.EJ17-0128","article-title":"C1qTNF-related protein 1 improve insulin resistance by reducing phosphorylation of serine 1101 in insulin receptor substrate 1","volume":"64","author":"Xin","year":"2017","journal-title":"Endocr. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jnutbio.2015.08.018","article-title":"CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation","volume":"27","author":"Han","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1074\/jbc.M111.278333","article-title":"CTRP1 Protein Enhances Fatty Acid Oxidation via AMP-activated Protein Kinase (AMPK) Activation and Acetyl-CoA Carboxylase (ACC) Inhibition","volume":"287","author":"Peterson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E678\u201397","DOI":"10.1152\/ajpendo.00087.2016","article-title":"Loss of CTRP1 disrupts glucose and lipid homeostasis","volume":"311","author":"Rodriguez","year":"2016","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.05.004","article-title":"C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway","volume":"121","author":"Wu","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2013.01.002","article-title":"A novel adipokine C1q\/TNF-related protein 1 (CTRP1) regulates chondrocyte proliferation and maturation through the ERK1\/2 signaling pathway","volume":"369","author":"Akiyama","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_29","unstructured":"(2026, April 08). Covidence Systematic Review Software, Veritas Health Innovation, Melbourne, Australia. Available online: www.covidence.org."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wan, X., Wang, W., Liu, J., and Tong, T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-135"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","article-title":"Extracting data from figures with software was faster, with higher interrater reliability than manual extraction","volume":"74","author":"Vucic","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"ref_33","unstructured":"(2025, December 17). PlotDigitizer. PlotDigitizer. Available online: https:\/\/plotdigitizer.com\/."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4082\/kjfm.23.0034","article-title":"RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions","volume":"44","author":"Seo","year":"2023","journal-title":"Korean J. Fam. Med."},{"key":"ref_35","unstructured":"National Institutes of Health (2025, December 17). Study Quality Assessment Tools, Available online: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jclinepi.2020.09.044","article-title":"Quality versus Risk-of-Bias assessment in clinical research","volume":"129","author":"Xu","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2022.07.015","article-title":"GRADE guidance 35: Update on rating imprecision for assessing contextualized certainty of evidence and making decisions","volume":"150","author":"Neumann","year":"2022","journal-title":"J. Clin. Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: A practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"ref_41","unstructured":"Kossmeier, M., Tran, U.S., and Voracek, M. (2026, February 23). metaviz: Forest Plots, Funnel Plots, and Visual Funnel Plot Inference for Meta-Analysis. CRAN: Contributed Packages. R Package Version 0.3.1. Available online: https:\/\/CRAN.R-project.org\/package=metaviz."},{"key":"ref_42","unstructured":"Harrer, M., Cuijpers, P., Furukawa, T., and Ebert, D.D. (2026, February 23). dmetar: Companion R Package for the Guide \u2018Doing Meta-Analysis in R\u2019. R Package Version 0.1.0. Available online: http:\/\/dmetar.protectlab.org\/."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"ref_44","unstructured":"dmetar (2026, February 27). Influence Diagnostics. Available online: https:\/\/dmetar.protectlab.org\/reference\/influenceanalysis#ref-usage."},{"key":"ref_45","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., Welch, V., and Flemyng, E. (2024). Cochrane Handbook for Systematic Reviews of Interventions, Cochrane. Available online: www.cochrane.org\/handbook."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and Fill: A Simple Funnel-Plot\u2013Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"ref_48","first-page":"43","article-title":"Power-Enhanced Funnel Plots for Meta-Analysis","volume":"228","author":"Kossmeier","year":"2020","journal-title":"Z. Psychol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1037\/a0033242","article-title":"P-curve: A key to the file-drawer","volume":"143","author":"Simonsohn","year":"2014","journal-title":"J. Exp. Psychol. Gen."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bai, B., Ban, B., Liu, Z., Zhang, M.M., Tan, B.K., and Chen, J. (2017). Circulating C1q complement\/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172271"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5479627","DOI":"10.1155\/2016\/5479627","article-title":"Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21","volume":"2016","author":"Han","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13098-021-00631-w","article-title":"The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: A preliminary study","volume":"13","author":"Majidi","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Pan, X., Lu, T., Wu, F., Jin, L., Zhang, Y., Shi, L., Li, X., and Lin, Z. (2014). Circulating Complement-C1q TNF-Related Protein 1 Levels Are Increased in Patients with Type 2 Diabetes and Are Associated with Insulin Sensitivity in Chinese Subjects. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094478"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shabani, P., Naeimi Khaledi, H., Beigy, M., Emamgholipour, S., Parvaz, E., Poustchi, H., and Doosti, M. (2015). Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118650"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1507\/endocrj.EJ14-0016","article-title":"Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients","volume":"61","author":"Xin","year":"2014","journal-title":"Endocr. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yagmur, E., Buergerhausen, D., Koek, G.H., Weiskirchen, R., Trautwein, C., Koch, A., and Tacke, F. (2019). Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050661"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hozo, S.P., Djulbegovic, B., and Hozo, I. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol., 5.","DOI":"10.1186\/1471-2288-5-13"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.26444\/aaem\/172122","article-title":"The correlation between two potentially antagonistic human adipocytokines, WISP-1 and CTRP1, and their association with insulin resistance","volume":"30","author":"Mirr","year":"2023","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.febslet.2006.06.034","article-title":"Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 increases CTRP1 expression in adipose tissue","volume":"580","author":"Yong","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ckj\/sfy095","article-title":"Obesity and chronic kidney disease progression\u2014The role of a new adipocytokine: C1q\/tumour necrosis factor-related protein-1","volume":"12","author":"Barbieri","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","article-title":"The sexual dimorphism of obesity","volume":"402","author":"Palmer","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_64","first-page":"166853","article-title":"White adipose tissue: Distribution, molecular insights of impaired expandability, and its implication in fatty liver disease","volume":"1869","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/oby.2010.56","article-title":"Sex- and Depot-Dependent Differences in Adipogenesis in Normal-Weight Humans","volume":"18","author":"Tchoukalova","year":"2010","journal-title":"Obesity"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Tchernof, A., Brochu, D., Maltais-Payette, I., Mansour, M.F., Marchand, G.B., Carreau, A., and Kapeluto, J. (2018). Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans. Comprehensive Physiology, Wiley.","DOI":"10.1002\/cphy.c170009"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2337\/diabetes.51.10.2951","article-title":"Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging","volume":"51","author":"Gabriely","year":"2002","journal-title":"Diabetes"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ijo.0801871","article-title":"A pilot study of long-term effects of a novel obesity treatment: Omentectomy in connection with adjustable gastric banding","volume":"26","author":"Apelman","year":"2002","journal-title":"Int. J. Obes."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e160823219824","DOI":"10.2174\/1573399820666230816111624","article-title":"Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases","volume":"20","year":"2024","journal-title":"Curr. Diabetes Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.bbrc.2010.10.104","article-title":"Insulin metabolism in human adipocytes from subcutaneous and visceral depots","volume":"402","author":"Fawcett","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: Structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1007\/s00125-010-1889-3","article-title":"Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity","volume":"53","author":"Hoffstedt","year":"2010","journal-title":"Diabetologia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Chait, A., and den Hartigh, L.J. (2020). Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00022"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1159\/000479915","article-title":"Association Between C1q\/TNF-Related Protein-1 Levels in Human Plasma and Epicardial Adipose Tissues and Congestive Heart Failure","volume":"42","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/dc09-1392","article-title":"Ethnic Variation in Adiponectin and Leptin Levels and Their Association with Adiposity and Insulin Resistance","volume":"33","author":"Mente","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/eje.0.1510361","article-title":"Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes","volume":"151","author":"Gottsater","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coph.2010.08.002","article-title":"Mechanisms of adiponectin regulation and use as a pharmacological target","volume":"10","author":"Phillips","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12020-024-04085-8","article-title":"Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: A preliminary longitudinal study","volume":"87","author":"Baldassini","year":"2024","journal-title":"Endocrine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"111076","DOI":"10.1016\/j.diabres.2023.111076","article-title":"The effect of metformin on adipokines levels: A systematic review and meta-analysis of randomized-controlled trials","volume":"207","author":"Zhao","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.56782\/pps.183","article-title":"Drugs and chemical substances inducing diabetes\u2014Review of the literature","volume":"22","author":"Oleksa","year":"2024","journal-title":"Prospect. Pharm. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:21:41Z","timestamp":1785313301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":82,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156775"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156775","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}